Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001172661-26-005056

Stakes reported in this filing

Reporting person Shares Of the class
BALYASNY ASSET MANAGEMENT L.P. 7,225,439 7.94%
BAM GP LLC 7,225,439 7.94%
Balyasny Asset Management Holdings LP 7,225,439 7.94%
Dames GP LLC 7,225,439 7.94%
Dmitry Balyasny 7,225,439 7.94%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…